Zhitong Finance App News, Shengnuo Biotech (688117.SH) issued an announcement. Meishan Huilong Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Meishan Huilong”), a wholly-owned subsidiary of the company, recently received the “Pharmaceutical Production License” and “Drug GMP Compliance Inspection Notice” approved and issued by the Sichuan Drug Administration.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Shengnuo Biotech (688117.SH) issued an announcement. Meishan Huilong Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Meishan Huilong”), a wholly-owned subsidiary of the company, recently received the “Pharmaceutical Production License” and “Drug GMP Compliance Inspection Notice” approved and issued by the Sichuan Drug Administration.